Abstract
Germline mutations in TP53 are associated with Li-Fraumeni syndrome (LFS), a complex and autosomal dominant syndrome, characterized by familial association of sarcomas. Breast cancer, brain tumors and adrenocortical carcinomas, are often diagnosed in these patients before they reach the age of 45. Just over 50% of individuals diagnosed with LFS have mutations in TP53, where as, the other …